Nature Communications · 2024 · 30 citations · 44 references
Life SciencesMolecular BiologyOncologyChromatin BiologyDna RepairMolecular OncologyApoptosis ResistanceChromatinDna Damage SignalingHistone ProteinsAbasic SitesApurinic EndonucleasesChromatin RemodelingChromatin Remodeling After Dna DamageParp InhibitionParp Inhibitor SensitivityPoly Adp-ribose Polymerase InhibitorsPoly(adp-ribose) Polymerase Inhibitors
Clinical success with poly (ADP-ribose) polymerase inhibitors (PARPi) is impeded by inevitable resistance and associated cytotoxicity. Depletion of Amplified in Liver Cancer 1 (ALC1), a chromatin-remodeling enzyme, can overcome these limitations by hypersensitizing BReast CAncer genes 1/2 (BRCA1/2) mutant cells to PARPi. Here, we demonstrate that PARPi hypersensitivity upon ALC1 loss is reliant on its role in promoting the repair of chromatin buried abasic sites. We show that ALC1 enhances the ability of the abasic site processing enzyme, Apurinic/Apyrimidinic endonuclease 1 (APE1) to cleave nucleosome-occluded abasic sites. However, unrepaired abasic sites in ALC1-deficient cells are readily accessed by APE1 at the nucleosome-free replication forks. APE1 cleavage leads to fork breakage and trapping of PARP1/2 upon PARPi treatment, resulting in hypersensitivity. Collectively, our studies reveal how cells overcome the chromatin barrier to repair abasic lesions and uncover cleavage of abasic sites as a mechanism to overcome limitations of PARPi. Loss of Amplified in Liver Cancer 1 (ALC1) has been shown to confer PARP inhibitor hypersensitivity in BRCA-mutant cells. Here, the authors show that in ALC1-deficient BRCA-mutant cells, APE1 cleaves abasic sites at the forks resulting in DNA breaks and thereby enhances PARP inhibitor sensitivity.
44
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai, Shar-yin N. Huang, Benu Brata Das et al. · Cancer Research · 2012 · 2.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke, Rileen Sinha, Douglas A. Levine et al. · Nature Communications · 2013 · 1.5K citations · Full text
Replication fork stability confers chemoresistance in BRCA-deficient cells
Arnab Ray Chaudhuri, Elsa Callén, Xia Ding et al. · Nature · 2016 · 932 citations · Full text
Poly(ADP-ribose)–Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1
Dragana Ahel, Zuzana Hořejšı́, Nicola Wiechens et al. · Science · 2009 · 596 citations · Full text